elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28543732-55F9DF12-E703-4A8B-9ACC-DB0AB5003CDE
Q28543732-55F9DF12-E703-4A8B-9ACC-DB0AB5003CDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543732-55F9DF12-E703-4A8B-9ACC-DB0AB5003CDE
Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection
P2093
Q28543732-55F9DF12-E703-4A8B-9ACC-DB0AB5003CDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543732-55F9DF12-E703-4A8B-9ACC-DB0AB5003CDE
rank
NormalRank
type
BestRank
Statement
P1545
8
http://www.w3.org/2001/XMLSchema#string
P2093
Stephen J Kerr
http://www.w3.org/2001/XMLSchema#string